177
Views
5
CrossRef citations to date
0
Altmetric
Articles

Do racial differences exist in the association between pregnancy-induced hypertension and breast cancer risk?

, , , , , & show all
Pages 138-144 | Received 29 Aug 2016, Accepted 04 Nov 2016, Published online: 19 Jan 2017

References

  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014;2:e23–e33.
  • Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstetrics Gynaecol 2011;25:391–403.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014;10:466–80.
  • Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet (London, England) 2010;376:631–44.
  • Warrington JP, George EM, Palei AC, et al. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 2013;62:666–73.
  • Terry MB, Perrin M, Salafia CM, et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007;165:1007–14.
  • Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology (Cambridge, Mass) 1999;10:722–32.
  • Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control: CCC 2010;21:967–89.
  • Troisi R, Innes KE, Roberts JM, Hoover RN. Preeclampsia and maternal breast cancer risk by offspring gender: Do elevated androgen concentrations play a role? Br J Cancer 2007;97:688–90.
  • Ingec M, Gursoy HG, Yildiz L, et al. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstetrics Off Org Int Fed Gynaecol Obstetrics 2004;84:214–9.
  • Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstetrics Gynecol Reprod Biol 2006;126:16–9.
  • Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
  • Kim JS, Kang EJ, Woo OH, et al. The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncologica (Stockholm, Sweden) 2013;52:1643–8.
  • Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002;87:971–3.
  • Vatten LJ, Forman MR, Nilsen TI, et al. The negative association between pre-eclampsia and breast cancer risk may depend on the offspring’s gender. Br J Cancer 2007;96:1436–8.
  • Opdahl S, Romundstad PR, Alsaker MD, Vatten LJ. Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 2012;107:176–82.
  • Hajiebrahimi M, Cnattingius S, Lambe M, Bahmanyar S. Pregnancy history and risk of premenopausal breast cancer-a nested case-control study. Int J Epidemiol 2016;45:816–824.
  • Pacheco NL, Andersen AN, Kamper-Jorgensen M. Preeclampsia and breast cancer: The influence of birth characteristics. Breast (Edinburgh, Scotland) Breast 2015;24:613–617.
  • Richardson BE, Peck JD, Wormuth JK. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:1349–55.
  • Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004;112:306–11.
  • Ma H, Henderson KD, Sullivan-Halley J, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res: BCR 2010;12:R35.
  • Mogren I, Stenlund H, Hogberg U. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncologica (Stockholm, Sweden) 2001;40:849–54.
  • Cnattingius S, Torrang A, Ekbom A, et al. Pregnancy characteristics and maternal risk of breast cancer. JAMA 2005;294:2474–80.
  • Paltiel O, Friedlander Y, Tiram E, et al. Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 2004;328:919.
  • Calderon-Margalit R, Friedlander Y, Yanetz R, et al. Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstetrics Gynecol 2009;200:63 e1–5.
  • Jia M, Andreassen T, Jensen L, et al. Estrogen receptor alpha promotes breast cancer by reprogramming choline metabolism. Cancer Res 2016;76:5634–5646.
  • Cai Q, Shu XO, Jin F, et al. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12:853–9.
  • Pan Z, Fu Z, Song Q, et al. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women. Genet Mol Res: GMR 2016;15.
  • Chen L, Kang H, Jin GJ, et al. The association between a novel polymorphism (rs1062577) in ESR1 and breast cancer susceptibility in the Han Chinese women. Gynecol Endocrinol 2016:1–4.
  • Zhang L, Gu L, Qian B, et al. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat 2009;114:327–38.
  • El-Beshbishy HA, Tawfeek MA, Al-Azhary NM, et al. Estrogen Receptor Alpha (ESR1) Gene Polymorphisms in Pre-eclamptic Saudi Patients. Pak J Med Sci 2015;31:880–5.
  • Molvarec A, Ver A, Fekete A, et al. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res Off J Jpn Soc Hypertens 2007;30:205–11.
  • Zhang Y, Zhang M, Yuan X, et al. Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis. Med Sci Monit Int Med J Exp Clin Res 2015;21:2986–96.
  • Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 2014;144:1–10.
  • Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA: A Cancer J Clinicians 2006;56:168–83.
  • Cohn BA, Cirillo PM, Christianson RE, et al. Placental characteristics and reduced risk of maternal breast cancer. J National Cancer Inst 2001;93:1133–40.
  • Mucci LA, Lagiou P, Tamimi RM, et al. Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes & Control: CCC 2003;14:311–8.
  • Eskild A, Romundstad PR, Vatten LJ. Placental weight and birthweight: does the association differ between pregnancies with and without preeclampsia? Am J Obstetrics Gynecol 2009;201:595.e1–5.
  • Phad N, Dahlstrom JE, Ellwood D, Kent AL. The effect of pregnancy-induced hypertensive disorders on placental growth along short and long axes and neonatal outcomes. Aust N Z J Obstetrics Gynaecol 2015;55:239–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.